Shopping Cart

New SPAC: Willow Lane Acquisition Corp. (WLACU) Files for $110M IPO

new-spac

New SPAC: Willow Lane Acquisition Corp. (WLACU) Files for $110M IPO

Oct 4, 2024 Headline Post, INTEL, New S-1 Filings by Nicholas Alan Clayton

Willow Lane (NASDAQ:WLACU) has filed for a $110 million SPAC to be the latest repeat SPAC team returning to the market with the help of underwriter BTIG. BTIG is, in fact, leading recent underwriter activity with four new SPACs filed since the August 1, while no other firm has been left lead for more than
Read More

To access this post, you must purchase 1 - User: Monthly Plan.
SPAC-morning-roundup

Morning SPAC News Roundup: October 4, 2024

Oct 4, 2024 SPACs in the News by Nicholas Alan Clayton
At the SPAC of Dawn While SPACs settle into a slight pause through Rosh Hashanah, de-SPACs are also entering another period of holiday-based trading patterns. Traders following the usual “Sell in May and Go Away” pattern this year would have missed out on a major late-summer market rally. But, stocks may now feel the effects
Read More
To access this post, you must purchase 1 - User: Monthly Plan.
SPAC-morning-roundup
proxy-votes-corporate-actions-v2
new-spac

New SPAC: Ocean Capital Acquisition Corp. (OCACU) Files for $60M IPO

Oct 2, 2024 Headline Post, INTEL, New S-1 Filings by Kristi Marvin
Ocean Capital Acquisition Corporation (Nasdaq:OCACU) filed this morning for a $60 million offering to be underwritten by Brookline Capital Markets. This is only the second offering for Brookline where they will be in the position of sole bookrunner, with DT Cloud Acquisition Corporation being their first. However, Brookline has been a bookrunner to the right
Read More
To access this post, you must purchase 1 - User: Monthly Plan.
china pic

Iron Horse Acquisitions (IROH) to Combine with China Food Investment in $523M Deal

Oct 2, 2024 Deal Announcements & Amendments, Headline Post, INTEL by Nicholas Alan Clayton
Iron Horse (NASDAQ:IROH) has entered into a definitive agreement to combine with healthy food firm China Food Investment at a post-transaction enterprise value of $523 million. Hong Kong-based China Food investment distributes and advocates for healthy food products in Asia. The combined company is expected to trade on the Nasdaq once the deal is completed
Read More
To access this post, you must purchase 1 - User: Monthly Plan.
SPAC-morning-roundup
new-spac

New SPAC: A SPAC III Acquisition Corp. (ASPCU) Files for $55M IPO

Oct 1, 2024 Headline Post, INTEL, New S-1 Filings by Kristi Marvin
A SPAC III Acquisition Corp. (Nasdaq:ASPCU), is the third SPAC from the A SPAC team and intends to raise $55 million with Maxim Group as underwriters. A SPAC III will be focusing its search on the Environmental, Sustainability and Governance (ESG) and material technology sectors. The A SPAC team had previously launched two other SPACs,
Read More
To access this post, you must purchase 1 - User: Monthly Plan.
third-quarter-ytd-2024-spac-review
new-spac
SPAC-morning-roundup

Morning SPAC News Roundup: October 1, 2024

Oct 1, 2024 SPACs in the News by Nicholas Alan Clayton
At the SPAC of Dawn De-SPACs have long been targets of short-selling and the turnover that occurs after each completed deal provides some seemingly obvious opportunities for the shorts to exploit. Shorts have also tended to pile on companies following a disappointing round of earnings or the sort of profitability concerns that plagued many growth-stage
Read More
To access this post, you must purchase 1 - User: Monthly Plan.
lock-ups

SPAC Lock-Up Expirations to Watch in October 2024

Sep 30, 2024 Headline Post, INTEL by Nicholas Alan Clayton
October is likely to be the quietest month of 2024 in terms of SPAC partners coming unglued from their lock-up agreements, and it comes right on the heels of the most-watched lock-up expiry in quite some time. Although Trump Media’s (NASDAQ:DJT) unlocking did not release the same sparks that might have been anticipated, it did
Read More
To access this post, you must purchase 1 - User: Monthly Plan.
new-spac

New SPAC: Jackson Acquisition Company II (JACS.U) Files for $200M IPO

Sep 30, 2024 Headline Post, INTEL, New S-1 Filings by Nicholas Alan Clayton
Jackson II (NYSE:JACS.U) has filed for a $200 million SPAC with improved terms over the team’s last vehicle, which liquidated in 2023 without a having signed a deal. This SPAC would have some structures from the standard set of mid-2024 filings as it will not overfund its trust with $10.00 per share in the account
Read More
To access this post, you must purchase 1 - User: Monthly Plan.
SPAC-morning-roundup
SPAC-Terms-Tracker

SPAC IPO Terms Tracker: September 27, 2024

Sep 28, 2024 Headline Post, INTEL by Kristi Marvin
Terms Tracker for the Week Ending September 27, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Surprisingly, last week was fairly quiet. There was only one deal announcement, there were no IPOs priced and only two new Registration Statements filed from
Read More
To access this post, you must purchase 1 - User: Monthly Plan.
SPAC-morning-roundup
SPAC-morning-roundup
new-spac

New SPAC: Charlton Aria Acquisition Corporation (CHARU) Files for $75M IPO

Sep 25, 2024 Headline Post, INTEL, New S-1 Filings by Nicholas Alan Clayton
Charlton Aria (NASDAQ:CHARU) helps pick up the pace in new SPAC filings as its bid for a $75 million IPO becomes the fourth new entry in the past week after no SPACs filed in the first half of the September. It would also be the third SPAC brought to market by Clear Street, which debuted
Read More
To access this post, you must purchase 1 - User: Monthly Plan.

Breeze Holdings Acquisition Corp. (BRZH) to Combine with YD Biopharma in $694M Deal

Sep 25, 2024 Deal Announcements & Amendments, Headline Post, INTEL by Nicholas Alan Clayton
Breeze Holdings Acquisition Corp. (OTC:BRZH) has entered into a definitive agreement to combine with drug developer YD Biopharma at an enterprise value of $694 million. Taipei-based YD is developing a trio of treatment candidates meant to treat some eye conditions and screen for pancreatic and breast cancer, whose patents it has under license. The combined
Read More
To access this post, you must purchase 1 - User: Monthly Plan.